Concepedia

Publication | Open Access

Efficacy and Safety of Paliperidone Palmitate 3-Month Formulation for Patients with Schizophrenia: A Randomized, Multicenter, Double-Blind, Noninferiority Study

DOIFull Paper Access

159

Citations

15

References

2016

Year

Adam Savitz, Haiyan Xu, Srihari Gopal, Isaac Nuamah, Paulien Ravenstijn, Adam Janik, Alain Schotte, David Hough, Wolfgang Fleischhacker
The International Journal of Neuropsychopharmacology

Abstract

Taken together, PP3M with its 3-month dosing interval is a unique option for relapse prevention in schizophrenia.

References

YearCitations

Page 1